FICHIT

Je m'inscris

ADDEX THERAPEUTICS

0/5 (0 note(s))
Note donnée : aucune
Zurich
33
Orally available small molecule drugs, called allosteric modulators, to treat a broad range of diseases.
Diproglurant IR nGluRS NAM: Parkinson's disease levodopa induced Dyskinesia (PD-LID), currently in Phase II development, partially founded by Mychael J.Fox Foundation.
Diproglurant ER nGluRS NAM: Focal cervical dystonia, currently in Phase I development, in collaboration with Dystonia Medical Foundation.
ADX71149 nGluR2n PAM: Epilepsy, currently in phase I development, partenered with Janssen Pharmaceutical.
DYER Tim
www.addextherapeutics.com
ADXN:SW

Fiche créée le 10/04/2016 par Guillaume   vue 4 fois.